16-22 of 22
DKA in Focus: What the New Consensus Means for Practice
CME/CEDKA in Focus: What the New Consensus Means for Practice
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Jennifer Sherr, MD, PhD
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
CME/CENo Patient with CKD Left Behind! Emerging CKD Therapies in T1D
Richard E. Pratley, MD
David Cherney, MD, PhD
prof. Hiddo Heerspink
Nephrology at the Helm—Advancing Timely CKD Care Through Cross-Specialty Collaboration
CME/CENephrology at the Helm—Advancing Timely CKD Care Through Cross-Specialty Collaboration
Kelly B. Chen, MSN, AGACNP-BC
Chuck Vega, MD, FAAFP
Jay B. Wish, MD
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
CME/CEThe Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
prof. Hiddo Heerspink
Peter Rossing, MD, DMSc
Paola Fioretto, MD
Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
CME/CECase-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Prof. Dr. Francesc Xavier Cos Claramunt
Optimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy
CME/CEOptimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy
Amy Mottl, MD, MPH
Prof. Christoph Wanner
- advertisement
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
CME/CERevolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Scott Kahan, MD, MPH
Ken Fujioka, MD
Carol Wysham, MD